ORDAN MARK S
Chief Executive Officer
ORDAN MARK S has filed 3 SEC Form 4 filings (7 transaction rows) across 2 companies, including MD, CG, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 3, 2026.
On the most recent filing, ORDAN MARK S is listed as Chief Executive Officer at Pediatrix Medical Group, Inc. Inside the rolling window, ORDAN MARK S reported no open-market purchases and 1 open-market sale totaling $515K in MD.
Companies traded
Other insiders at MD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$515K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ORDAN MARK S made?
ORDAN MARK S has filed 3 SEC Form 4 filings (7 transaction rows) across 2 companies, including MD, CG since 2025.
Which companies does ORDAN MARK S trade?
ORDAN MARK S has filed SEC Form 4 disclosures for 2 companies, including MD, CG.
When was ORDAN MARK S's most recent SEC Form 4 filing?
ORDAN MARK S's most recent SEC Form 4 filing on Tracefour is dated Jun 3, 2026.
What is ORDAN MARK S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, ORDAN MARK S is listed as Chief Executive Officer.
What is ORDAN MARK S's total buy and sell value in the current window?
Inside the rolling retention window, ORDAN MARK S bought $0 and sold $515K based on SEC Form 4 filings.
What was ORDAN MARK S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 23,000 MD shares on 2025-12-15, worth $515K, per SEC Form 4 filings.